𝛼SK or Search

ENTITY

Deciphera Pharmaceuticals (DCPH US)

1

Analysis

Health Care • United States

Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.

more

Refresh

Exchange Announcement • 11 Jun 2024 21:25

Current Report (Form 8-K | Period ending 2024-06-11)

Exchange Announcement • 10 May 2024 19:27

Quarterly Report (Form 10-Q | Period ending 2024-03-31)

Exchange Announcement • 30 Apr 2024 18:08

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 30 Apr 2024 05:24

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 30 Apr 2024 05:23

SC14D9C | Written communication by the subject company relating to a third party tender offer

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x